Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...
The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the ...
Sexual and reproductive health counseling is insufficient among adolescents with rheumatic diseases, despite their understanding if its importance.
Although more research is needed in pediatric patients, biosimilars could improve treatment access and reduce costs.
MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be ...
Barriers to influenza vaccination among pediatric rheumatology patients on immunosuppression include concerns about disease flares and vaccine efficacy.
This raises the question of whether a pediatric practice should accept them despite their unvaccinated status or require proof of immunization before registration. Experts argue differently.
While no arthritis cure exists, speak with your doctor about medications and lifestyle changes. During menopause, estrogen production slows, which you may need to support bone and joint health.
Brittany Craiglow, MD, FAAD, analyzed the promising use of baricitinib for severe pediatric alopecia areata. She highlighted late-breaking data from the BRAVE-AA-PEDS study (NCT05723198), emphasizing ...
Vitamin C (L-ascorbic acid) is a powerful antioxidant that plays essential roles in joint health and immune function that may benefit people with arthritis. A growing body of research suggests the ...
for use in the first pediatric clinical trial, to evaluate if intravenous infusion affects signs and symptoms of oligoarticular or polyarticular juvenile idiopathic arthritis (JIA) and improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results